As you will be aware the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of Pegunigalsidase alfa for treating Fabry disease.
Please note that following on from advice received from the company the timelines for this appraisal have been revised. It is now anticipated that this appraisal will begin during late October 2022, when we will write to you about how you can get involved.